Fulcrum Therapeutics (FULC) Asset Utilization Ratio (2020 - 2025)

Fulcrum Therapeutics (FULC) has reported Asset Utilization Ratio for 6 consecutive years, with 0.34 the latest figure, recorded in Q2 2025.

• In Q2 2025, Asset Utilization Ratio rose 9.51% year-over-year to 0.34; the TTM figure through Jun 2025 stood at 0.34 (up 9.51% YoY), while the FY2024 annual figure was 0.31, up 2564.82% from the prior year.
• Asset Utilization Ratio grew to 0.34 in Q2 2025 per FULC's latest filing, from 0.3 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.34 in Q2 2025 and bottomed at 0.01 in Q3 2023.
• Historically, Asset Utilization Ratio has averaged 0.11 across 5 years, with a median of 0.07 in 2022.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio tumbled 85.94% — and 2024, when it surged 3064.27%.
• Fulcrum Therapeutics' Asset Utilization Ratio stood at 0.08 in 2021, then plunged by 65.79% to 0.03 in 2022, then sank by 60.89% to 0.01 in 2023, then jumped by 2735.39% to 0.3 in 2024, then gained by 14.47% to 0.34 in 2025.
• Business Quant data shows FULC's Asset Utilization Ratio at 0.34 in Q2 2025, 0.3 in Q4 2024, and 0.28 in Q3 2024.